Identifying the earliest altered circuit function in developing animal models of FXS is an important step toward elucidating mechanism, and developing treatments not only for FXS4, but also for non-syndromic autism spectrum disorders (ASD), as FMRP target genes comprise 14 of 27 high-risk genes for ASD5. This evidence concerns the gene FMR1 and fragile X syndrome.